Characterization of the sigma ligand panamesine by immune response during 
four-weeks treatment in patients with schizophrenia and by sleep-EEG changes in 
normal controls.

Frieboes, R. M.; Murck, H.; Antonijevic, I. A.; Kraus, T.; Hinze-Selch, D.; Pollmächer, T.; Steiger, A.

Lokale TagsFreigabegeschichteDetailsÜbersicht

Characterization of the sigma ligand panamesine by immune response during four-weeks treatment in patients with schizophrenia and by sleep-EEG changes in normal controls.

Frieboes, R. M., Murck, H., Antonijevic, I. A., Kraus, T., Hinze-Selch, D., Pollmächer, T., et al. (1999). Characterization of the sigma ligand panamesine by immune response during four-weeks treatment in patients with schizophrenia and by sleep-EEG changes in normal controls. Psychopharmacology, 141, 107-110.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A612-A Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-000E-A613-8

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Frieboes, R. M.¹, Autor
Murck, H.², Autor
Antonijevic, I. A., Autor
Kraus, T., Autor
Hinze-Selch, D., Autor
Pollmächer, T.¹, Autor
Steiger, A.², Autor

Affiliations:
1Max Planck Institute of Psychiatry, Max Planck Society, ou_1607137
2AG Steiger, Axel, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society, ou_1607160